Cyclical stocks suffered in 2022, but 2023 could be a banner year for growth stocks as inflation cools and the Fed eventually finishes the rate hiking cycle. Today we’re focusing on a deep value growth name that seems to be poised for a comeback as cyclicals regain...
Regardless of what’s happening elsewhere in the market, biopharma is a great place to look for stocks to pack into your portfolio because there’s always an illness that can be treated more effectively in the future than it is being treated today.
Our stock...
One area of the market where stocks can be found to produce 10x, even 20x returns, regardless of what’s happening elsewhere in the market, is biotech. Looking at the performance of the past ten years, if the biotechnology industry were a sector, it would be the...
Since 2003, when the number of poor and vulnerable people in the world reached a historical peak of 4.4 billion people, the middle class has been growing fast. By 2030, another 700 million people are expected to join the global middle class, making it more than...
Software stocks were among the market’s biggest losers in 2022 amid drastic shifts in Fed policy. But amid signs of cooling inflation over the past few months, the pace of interest rate hikes has slowed. With inflation collapsing, it seems likely that interest rates will...